Newsroom

Sorted by: Latest
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 27.03.2026 FPX. IE00BYTH6238  175,002.00 USD  10,161,803.05   58.067  ...
-

Le VinFast VF 9, meilleure option pour les familles nombreuses

MARKHAM, Ontario--(BUSINESS WIRE)--Il arrive un moment où un VUS compact ou intermédiaire devient insuffisant. Probablement parce que la famille s'agrandit. Les longs trajets sont peut-être plus fréquents. Ou peut-être souhaitez-vous simplement davantage de confort sans pour autant passer à un véhicule surdimensionné et énergivore. C’est généralement le moment où les acheteurs commencent à s’intéresser aux VUS pleine grandeur. Le problème, c’est qu’au Canada, opter pour un plus gros véhicule se...
-

Biocytogen erteilt Taisho Pharmaceutical eine Lizenz für seine RenNano®-Plattform zur Entwicklung von vollständig humanen, ausschließlich aus schweren Ketten bestehenden Antikörpern

PEKING & TOKIO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Peking) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), ein weltweit tätiges Biotechnologieunternehmen, das die Forschung und Entwicklung neuartiger, auf Antikörpern basierender Medikamente mit innovativen Technologien vorantreibt, hat heute den Abschluss einer Plattform-Lizenzvereinbarung mit Taisho Pharmaceutical Co., Ltd. („Taisho“) bekannt gegeben. Im Rahmen der Lizenzvereinbarung wird Taisho das Recht gewährt, auf die firmeneig...
-

Riassunto: Biocytogen concede a Taisho Pharmaceutical una licenza per la sua piattaforma RenNano® per l'identificazione di anticorpi completamente umani a catena pesante

BEIJING e TOKYO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), un'azienda biotecnologica globale a capo di ricerca e sviluppo di nuovi farmaci a base di anticorpi tramite tecnologie innovative, ha annunciato oggi di aver sottoscritto un accordo di licenza della piattaforma con Taisho Pharmaceutical Co., Ltd. ("Taisho"), che concederà a Taisho il diritto di accedere e utilizzare la piattaforma proprietaria di Biocytogen, RenNano® per il r...
-

Samenvatting: Biocytogen verleent Taisho Pharmaceutical een licentie op zijn RenNano®-platform voor de ontdekking van volledig menselijke antilichamen met uitsluitend zware ketens

BEIJING & TOKYO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), een wereldwijd biotechnologiebedrijf dat met innovatieve technologieën het onderzoek naar en de ontwikkeling van nieuwe, op antilichamen gebaseerde geneesmiddelen stimuleert, heeft vandaag bekendgemaakt dat het een platformlicentieovereenkomst heeft gesloten met Taisho Pharmaceutical Co., Ltd. ('Taisho'). Met deze overeenkomst verleent Biocytogen Taisho het recht op toegang t...
-

Resumen: Biocytogen concede a Taisho Pharmaceutical una licencia para su plataforma de descubrimiento de anticuerpos RenNano®, compuesta exclusivamente por cadenas pesadas totalmente humanas

PEKÍN Y TOKIO--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), una empresa biotecnológica internacional dedicada a la investigación y el desarrollo de nuevos fármacos basados en anticuerpos mediante tecnologías innovadoras, ha anunciado hoy la firma de un acuerdo de licencia de plataforma con Taisho Pharmaceutical Co., Ltd. («Taisho»), por el que se concede a Taisho el derecho a acceder y utilizar la plataforma de descubrimiento de anticue...
-

Idaho Legislature Unanimously Passes Veteran Protection Bill, Signed into Law by Governor Brad Little

WASHINGTON--(BUSINESS WIRE)--In a rare and powerful show of unity, every elected member of the Idaho Legislature voted in support of SB 1286, a Veteran protection bill, unanimously passing it through both chambers before being swiftly signed into law by Governor Brad Little. The National Association for Veterans Rights (NAVR) today applauded Idaho’s leadership in advancing a balanced, bipartisan framework that strengthens consumer protections while preserving Veterans’ ability to choose how the...
-

Bank of New York Mellon UK Regulatory Announcement: FRN Variable Rate Fix

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 3/30/2026 Issue ¦ Westpac Banking Corporation Series No 1560 GBP100,000,000 FRN Due in October 2026     ISIN Number ¦ XS2912343212 ISIN Reference ¦ 291234321 Issue Nomin GBP ¦ 100000000 Period ¦ 1/8/2026 to 4/8/2026   Payment Date 4/8/2026 Number of Days ¦ 90 Rate ¦ 4.11387   Denomination GBP ¦ 100000   ¦ 100000000   ¦       Amount Payable per Denomination ¦ 1014.38   ¦ 1014380   ¦       Bank of New...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 27.03.2026 GINC LN IE00BD842Y21  864,481.00 USD  52,347,138.12   60.553  ...
-

StackAdapt Named a Strong Performer in Omnichannel Advertising Platforms, Q1 2026 Analyst Evaluation

TORONTO--(BUSINESS WIRE)--StackAdapt (www.stackadapt.com), the leading AI advertising and orchestration platform, today announced it has been named a Strong Performer in The Forrester Wave™: Omnichannel Advertising Platforms, Q1 2026. The report evaluated top omnichannel advertising platforms across a comprehensive set of criteria across two categories—current offering and strategy—along with customer feedback. StackAdapt received the highest possible scores in three criteria, including self-se...